OVERSEA CHINESE BANKING Corp Ltd Invests $8.22 Million in MKS Inc. $MKSI

OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in MKS Inc. (NASDAQ:MKSI) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 18,477 shares of the scientific and technical instruments company’s stock, valued at approximately $8,219,000.

Several other hedge funds also recently added to or reduced their stakes in MKSI. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in MKS by 3.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after acquiring an additional 9,170 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of MKS by 63.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock valued at $83,000 after purchasing an additional 325 shares during the last quarter. First Trust Advisors LP grew its holdings in shares of MKS by 3,545.6% during the 2nd quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock worth $14,036,000 after purchasing an additional 137,392 shares during the period. Cerity Partners LLC acquired a new stake in shares of MKS during the 2nd quarter worth about $1,676,000. Finally, AXA S.A. increased its position in shares of MKS by 22.8% during the 2nd quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock worth $2,907,000 after purchasing an additional 5,430 shares during the last quarter. 99.79% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at MKS

In other MKS news, Director Joseph B. Donahue sold 2,100 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $327.95, for a total value of $688,695.00. Following the sale, the director owned 10,033 shares of the company’s stock, valued at $3,290,322.35. This trade represents a 17.31% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Michelle M. Mccarthy sold 2,434 shares of MKS stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $315.23, for a total value of $767,269.82. Following the completion of the transaction, the chief accounting officer owned 2 shares of the company’s stock, valued at $630.46. The trade was a 99.92% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 37,491 shares of company stock valued at $12,102,072 in the last 90 days. Insiders own 0.57% of the company’s stock.

MKS Trading Up 0.1%

NASDAQ MKSI opened at $281.88 on Friday. The firm has a 50 day simple moving average of $343.48 and a 200-day simple moving average of $294.36. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.72 and a current ratio of 1.14. MKS Inc. has a one year low of $97.50 and a one year high of $447.62. The firm has a market cap of $19.06 billion, a price-to-earnings ratio of 44.96, a PEG ratio of 0.60 and a beta of 1.98.

MKS (NASDAQ:MKSI) last announced its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.39. MKS had a net margin of 10.15% and a return on equity of 24.72%. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same period in the prior year, the firm earned $1.77 EPS. The firm’s revenue for the quarter was up 28.3% on a year-over-year basis. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. Equities research analysts anticipate that MKS Inc. will post 12.96 EPS for the current fiscal year.

MKS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Tuesday, August 25th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Tuesday, August 25th. MKS’s dividend payout ratio (DPR) is presently 15.95%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. BMO Capital Markets began coverage on shares of MKS in a research report on Tuesday, June 30th. They issued an “outperform” rating and a $453.00 target price on the stock. KeyCorp boosted their price target on shares of MKS from $360.00 to $475.00 and gave the company an “overweight” rating in a research note on Monday, June 29th. TD Cowen restated a “buy” rating on shares of MKS in a report on Thursday, May 7th. Needham & Company LLC increased their price objective on shares of MKS from $360.00 to $390.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Finally, Deutsche Bank Aktiengesellschaft set a $360.00 price target on MKS in a research report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $385.00.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high?technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.